Initiation of the multi-target anti-neuroinflammatory drug minocycline within 72 hours of acute ischemic stroke had a significant benefit in functional outcome compared to placebo, with no increased ...

NCD Academy is an online platform designed to empower the global primary care community with the knowledge, tools, and skills required to effectively address and mitigate the leading risk factors of ...

Since its inception in 2012, the ACC Geriatric Cardiology Section quickly gained momentum and now has over 1,000 members and well over 300 Fellows-in-Training (FITs), making it one of the larger ...

Using the ACC's health equity strategy, we aim to achieve a culture of equitable cardiovascular care and heart health for all. The ACC is paving the road to health equity through advocacy, education, ...

Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...

Long-term melatonin use for insomnia was associated with a higher hazard of heart failure (HF), an increase in HF hospitalizations and a doubling of all-cause mortality over five years, according to a ...

Mavacamten did not significantly improve exercise capacity as assessed by peak oxygen uptake or improve patient-reported health status compared with placebo in patients with symptomatic nonobstructive ...

Learn and stay certified — all in one program: The CMP blends continuous learning with assessment, making it an efficient, effective way to grow your expertise while maintaining your credentials.

We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...

The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).

Using real-world outcomes data from the STS/ACC TVT Registry, findings from the EVOQUE study presented at TCT 2025 demonstrate favorable safety and effectiveness of transcatheter tricuspid valve ...

Findings from the PREVUE-VALVE study presented at TCT 2025 shed light on the prevalence of valvular heart disease (VHD) and its subtypes among older Americans, as well as the influence of age, sex, ...